EichorEICHOR
Location: Clearwater Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Clearwater

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Clinical Research of West Florida, Inc. · Philip Morris Products S.A. · NCT07108166MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Morton Plant Hospital · NRG Oncology · NCT05624996A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Morton Plant Hospital · Agendia · NCT03053193Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · NRG Oncology · NCT05174169Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06632327Mitral Valve Screening Survey
Phase N/A · Morton Plant Hospital · Medstar Health Research Institute · NCT04736667Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial
NA · Mayo Clinic · NCT07670520Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before C
Phase 2 · Mayo Clinic · NCT06834373ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Morton Plant Hospital · Alliance for Clinical Trials in Oncology · NCT06876714Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · National Cancer Institute (NCI) · NCT04269902Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
NA · Mayo Clinic · NCT06325046Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Canadian Cancer Trials Group · NCT06592924Prevail Global Study
NA · BayCare Health System · Medtronic Vascular · NCT06535854Cystatin and Early AKI Detection Contrast Induced Acute Kidney Injury
Phase N/A · Morton Plant Hospital · BayCare Health System · NCT07197957A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Innovative Research of West Florida /ID# 257356 · AbbVie · NCT06345339SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
Phase 2 · Mayo Clinic · NCT05222620E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · NRG Oncology · NCT06748222An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · NRG Oncology · NCT03180268A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Tampa Bay Medical Research, Inc. · Hoffmann-La Roche · NCT07351058A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Innovative Research of West Florida, Inc. · Uniquity One (UNI) · NCT06496620Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning
Phase N/A · Mayo Clinic · NCT06200116STOP AF First Post-Approval Study
Phase N/A · BayCare Medical Group Cardiology · Medtronic Cardiac Ablation Solutions · NCT05227053Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Phase N/A · Alliance for Clinical Trials in Oncology · NCT04242095Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIR
Phase 3 · Clinical Res Of W Florida · Novartis Pharmaceuticals · NCT06133972Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · National Cancer Institute (NCI) · NCT05256225WE-CARE Community Health Forums to Increase Breast Cancer Screening and Clinical Trial Participation for Rural and Low I
NA · Mayo Clinic · NCT07644702SELUTION 4 De Novo Small Vessel IDE Trial
NA · Mease Countryside Hospital · M.A. Med Alliance S.A. · NCT05946629
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.